Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation
Vox Sanguinis · 2025
DOI: 10.1111/vox.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Frederik Banch Clausen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Genotyping Techniques, Prenatal Diagnosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, The Danish Blood Donors' Research Foundation, Clinical Center.
Abstract (Originalsprache)
Background and Objectives Noninvasive fetal antigen genotyping can assist the management of immunized pregnant women, and fetal RHD genotyping can be used as a screening assay to guide restricted use of Rh prophylaxis. Based on a survey, we present an overview of the implementation of noninvasive fetal antigen genotyping into clinical practice. Materials and Methods A survey was developed and sent out to the members of the International Society of Blood Transfusion (ISBT) working party on Red Cell Immunogenetics and Blood Group Terminology and to participants of the international noninvasive fetal RHD genotyping programme from the Danish Institute for External Quality Assurance for Laboratories in the health sector (DEKS). The survey contained four sections: fetal RHD screening, fetal RHD genotyping for RhD immunized women, fetal genotyping of other antigen targets than RhD and a section for collecting topics for future collaboration. The survey data were evaluated by the core author group.
Results
Fifty‐two survey responders were from 22 countries. Fetal RHD screening was implemented by 73%, foremost using real‐time PCR with in‐house assays, primarily, or commercially available kits. Most laboratories use the same assay for RhD immunized women. Thirty‐eight percent of the responders test for other antigen targets than RhD, using either real‐time PCR, droplet digital PCR (ddPCR) or DNA sequencing. There was an interest in collaborations on topics across methodology, technology, strategy and health care regulations.
Conclusion
In general, we found that noninvasive fetal blood group antigen genotyping is well implemented. However, our results are biased towards high‐income countries, Europe and laboratories already running noninvasive fetal antigen genotyping.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- cfDNA Subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.
- Department of Clinical Immunology and Transfusion Medicine, Office of Medical Service, Region Skåne, Lund, Sweden.
- Laboratory of the French National Reference Center in Perinatal Hemobiology, Assistance Publique des de Paris (AP-HP), Paris, France.
- Center of Fetal Medicine, Department of Gynecology, Fertility and Pregnancy, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Immunohaematology Diagnostic Services, Sanquin Diagnostic Services and Sanquin Research, Amsterdam, The Netherlands.
ORCID-Profile: Frederik Banch Clausen, Cécile Toly-Ndour, Masja de Haas
Förderung
- Intramural NIH HHS
- The Danish Blood Donors' Research Foundation
- Clinical Center
Zitieren
APA
Clausen, F. B., Hellberg, Å., Toly-Ndour, C., Nielsen, E. T., de Haas, M., & Noninvasive Fetal Antigen Genotyping Survey Group (2025). Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation. Vox Sanguinis. https://doi.org/10.1111/vox.70062
Vancouver
Clausen FB, Hellberg Å, Toly-Ndour C, Nielsen ET, de Haas M, Noninvasive Fetal Antigen Genotyping Survey Group. Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation. Vox Sanguinis. 2025. doi:10.1111/vox.70062
BibTeX
@article{Clausen2025,
author = {Clausen, Frederik Banch and Hellberg, Åsa and Toly-Ndour, Cécile and Nielsen, Emilie Thorup and de Haas, Masja and Noninvasive Fetal Antigen Genotyping Survey Group, Noninvasive Fetal Antigen Genotyping Survey Group},
title = {Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation},
journal = {Vox Sanguinis},
year = {2025},
doi = {10.1111/vox.70062}
}
EUVIMED